Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance-Reference-Cited by-同舟云学术

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance

Published:2012-09 Issue:3 Volume:51 Page:336-341
ISSN:1028-4559
Container-title:Taiwanese Journal of Obstetrics and Gynecology
language:en
Short-container-title:Taiwanese Journal of Obstetrics and Gynecology

Author:

Chuang Yin-Ting,Chang Chih-Long

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology

Reference49 articles.

1. Survival benefits with diverse chemotherapy regimens for ovarian cancer: meta-analysis of multiple treatments;Kyrgiou;J Natl Cancer Inst,2006

2. Response of patients in phase II studies of chemotherapy in ovarian cancer: implications for patient treatment and the design of phase II trials;Blackledge;Br J Cancer,1989

3. Treatment of relapsed carcinoma of the ovary with cisplatin or carboplatin following initial treatment with these compounds;Gore;Gynecol Oncol,1990

4. Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin;Markman;J Clin Oncol,1991

5. Topotecan versus paclitaxel for the treatment of recurrent epithelial ovarian cancer;ten Bokkel Huinink;J Clin Oncol,1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inactivation of VRK1 sensitizes ovarian cancer to PARP inhibition through regulating DNA-PK stability;Experimental Cell Research;2024-05

2. High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer;Diagnostic Pathology;2024-01-04

3. Development and Perspectives: Multifunctional Nucleic Acid Nanomedicines for Treatment of Gynecological Cancers;Small;2023-07-30

4. High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer;2023-07-27

5. Analysis of risk factors for negative emotions in perioperative period of ovarian cancer patients and their impact on prognosis;Gland Surgery;2023-04